Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2BENAZEPRIL HYDROCHLORIDE
02 2BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
03 1CLOPIDOGREL BISULFATE
04 1DESLORATADINE
05 1DIETHYLPROPION HYDROCHLORIDE
06 1ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
07 2FOSINOPRIL SODIUM
08 1FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
09 1GUAIFENESIN
10 1MOEXIPRIL HYDROCHLORIDE
11 1NEVIRAPINE
12 1ORPHENGESIC
13 1ORPHENGESIC FORTE
14 1RENVELA
15 4SEVELAMER CARBONATE
16 1SEVELAMER HYDROCHLORIDE
17 1TENUATE
18 1TENUATE DOSPAN
01 111722
02 112546
03 122127
04 275141
05 176274
06 176402
07 176483
08 176486
09 176631
10 176906
11 176961
12 177128
13 178355
14 178454
15 178794
16 178912
17 1200177
18 1200959
19 1204451
20 1204621
21 1204724
22 1206094
23 1207288
01 23No
02 1Yes
Drug : SEVELAMER CARBONATE
Dosage Form : TABLET; ORAL
Application Number : 206094
Country : US
Patented : No
Drug : NEVIRAPINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 204621
Country : US
Patented : No
Drug : SEVELAMER CARBONATE
Dosage Form : TABLET; ORAL
Application Number : 207288
Country : US
Patented : No
Drug : CLOPIDOGREL BISULFATE
Dosage Form : TABLET; ORAL
Application Number : 76274
Country : US
Patented : No
Drug : FOSINOPRIL SODIUM
Dosage Form : TABLET; ORAL
Application Number : 76906
Country : US
Patented : No
Drug : MOEXIPRIL HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 78454
Country : US
Patented : No
Drug : SEVELAMER HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 204724
Country : US
Patented : No
Drug : SEVELAMER CARBONATE
Dosage Form : TABLET; ORAL
Application Number : 204451
Country : US
Patented : No
Drug : SEVELAMER CARBONATE
Dosage Form : TABLET; ORAL
Application Number : 200959
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?